# Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.

> **NCT05528614** · — · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 51 (actual)

## Conditions studied

- Tumor of Pancreas

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05528614
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-13
- **Primary completion:** 2022-11-13
- **Final completion:** 2023-01-13
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05528614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05528614, "Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05528614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*